Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Dexamethasone sodium phosphate; neomycin sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for dexamethasone sodium phosphate; neomycin sulfate and what is the scope of dexamethasone sodium phosphate; neomycin sulfate patent protection?

Dexamethasone sodium phosphate; neomycin sulfate
is the generic ingredient in three branded drugs marketed by Alcon Pharms Ltd, Merck, Pharmafair, and Bausch And Lomb, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for dexamethasone sodium phosphate; neomycin sulfate.

Summary for Generic Name: dexamethasone sodium phosphate; neomycin sulfate

Tradenames:3
Patents:1
Applicants:4
NDAs:5
Drug Master File Entries: see list39
Clinical Trials: see list2,288
Drug Prices:see low prices
DailyMed Link:dexamethasone sodium phosphate; neomycin sulfate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC062539-001Jan 10, 1985DISCNNoNo► Subscribe► Subscribe
Alcon Pharms Ltd
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC062714-001Jul 21, 1986DISCNNoNo► Subscribe► Subscribe
Bausch And Lomb
NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC064055-001Oct 30, 1995DISCNNoNo► Subscribe► Subscribe
Merck
NEODECADRON
dexamethasone sodium phosphate; neomycin sulfate
OINTMENT;OPHTHALMIC050324-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Merck
NEODECADRON
dexamethasone sodium phosphate; neomycin sulfate
SOLUTION/DROPS;OPHTHALMIC050322-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot